Statistics
Publications
59
Citations
9.6K
H-Index
37
Active since
1985
Dashyant Dhanak is an author at GlaxoSmithKline (United States) specializing in medicinal chemistry, pharmacology, and medicine.
Publications per year
1985–2024
59
59
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
Michael T. McCabe, Heidi M. Ott, Gopinath Ganji et al. · Nature · 2012 · 1.8K citations
Targeting KRAS Mutant Cancers with a Covalent G12C-Specific Inhibitor
Matthew R. Janes, Jingchuan Zhang, Lian‐Sheng Li et al. · Cell · 2018 · 1.2K citations · Full text
ATP citrate lyase inhibition can suppress tumor cell growth
Georgia Hatzivassiliou, Fangping Zhao, Daniel E. Bauer et al. · Cancer Cell · 2005 · 1.1K citations · Full text
The promise and peril of chemical probes
C.H. Arrowsmith, James E. Audia, Christopher P. Austin et al. · Nature Chemical Biology · 2015 · 850 citations · Full text
1–5 of 59